• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Infectious Disease

Antibiotic use prevalent among hospitalized patients in the US

byJeffrey CohenandPriyanka Vedak
October 7, 2014
in Infectious Disease
Reading Time: 3 mins read
Pediatric chronic pain patients typically Caucasian, female adolescents.
Share on FacebookShare on Twitter

1. About 50% of hospitalized individuals in the United States received antibiotics in 2011.

2. Vancomycin was the most commonly used antibiotic for community and hospital acquired infections in critical care and non-critical care settings in the United States in 2011.

Evidence Rating Level: 4 (Below Average)

Study Rundown: Antibiotics have saved countless lives, but inappropriate use of antibiotics can harm patients and promote drug-resistant organisms. An initial step in evaluating the efficacy of antibiotic usage is to characterize antibiotic administration patterns. This study analyzed hospital antibiotic use data from hospitals in 10 states that were included in the Emerging Infection Program of the Centers of Disease Control and Prevention in 2011. Data was collected from small (<150 beds), medium (150-399 beds), and large (>400 beds) hospitals based on whether a patient was scheduled to receive antibiotics on the day of or before the survey, the patient was on dialysis and getting antibiotics within the 4 days prior to the survey day, or the patient’s antibiotic data was unknown for the survey day. Charts of patients meeting one of these criteria were reviewed for the antibiotic administered and the indication for its use.

Antibiotics were administered to about 50% of patients. Vancomycin was the most commonly administered antibiotic for both community (13.7%) and hospital-acquired (15.9%) infections. Vancomycin was also the most commonly used antibiotic in both critical care (34.9%) and non-critical care (23.7%) settings, followed by piperacillin-tazobactam in critical care settings (25.6%) and ceftriaxone in non-critical care settings (20.2%). Strengths of this study include the careful analysis of patients’ records, the inclusion of hospitals of multiple sizes from 10 states across the United States, and the inclusion of the indication for antibiotic use. One weakness of the study is that the data is from 2011, and may not reflect the most recent trends in antimicrobial therapy. Thus, while this study demonstrated that broad-spectrum antibiotics that are effective against highly resistant organisms are commonly used, further research is required to understand when and how frequently these agents are used in order to curb inappropriate administration.

Click to read the study, published today in JAMA

RELATED REPORTS

Nuzolvence (Zoliflodacin) first oral Gonorrhea treatment shows non-inferior cure rates

2 Minute Medicine: Pharma Roundup – New oral gonorrhea antibiotic Nuzolvence (zoliflodacin), late‑December cardiovascular and oncology drug approvals, first targeted complement inhibitor therapy for HSCT‑TMA (Yartemlea), and antibody‑drug conjugate (ADC) safety concerns with ifinatamab deruxtecan (I‑DXd) [January 2026]

Oral gepotidacin is non-inferior to standard therapy for uncomplicated urogenital gonorrhea

Relevant Reading: Vital signs: improving antibiotic use among hospitalized patients.

In-Depth [cross-sectional study]: This study analyzed antibiotic use and rationale for use data from 183 small, medium, or large hospitals across 10 states in 2011. Antibiotics were administered to 49.9% of patients (95%CI 49.0-50.9). Of these patients, 75.9% (95%CI 74.8-77.0) were receiving antibiotics to treat an infection. The remainder of patients received antibiotics for prophylaxis (medical 6.9%; surgical 19.0%) or for non-infectious (0.71%) or undocumented reasons (6.9%). Vancomycin was the most commonly used antibiotic for community- (13.7%) and hospital-acquired infections (15.9%) in both critical (34.9%) and non-critical (23.7%) care settings. This was followed by piperacillin-tazobactam in critical care settings (25.6%) and ceftriaxone in non-critical care settings (20.2%).

More from this author: Ambulances equipped for thrombolysis allow for more rapid stroke treatment, Stem cell transplant may be effective in sickle cell disease, Low carb and low fat diets most effective for weight loss, Climate change has important impact on health, Vitamin D supplementation in the ICU does not improve outcomes [VITdAL-ICU trial]

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: antibioticAntibiotic prophylaxis
Previous Post

Antibiotic prescription patterns in China may contribute to resistance

Next Post

Quality of life measures similar between teens with and without cerebral palsy

RelatedReports

USPSTF recommends routinely screening asymptomatic women for chlamydia and gonorrhea
Infectious Disease

Nuzolvence (Zoliflodacin) first oral Gonorrhea treatment shows non-inferior cure rates

January 14, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Cardiology

2 Minute Medicine: Pharma Roundup – New oral gonorrhea antibiotic Nuzolvence (zoliflodacin), late‑December cardiovascular and oncology drug approvals, first targeted complement inhibitor therapy for HSCT‑TMA (Yartemlea), and antibody‑drug conjugate (ADC) safety concerns with ifinatamab deruxtecan (I‑DXd) [January 2026]

January 26, 2026
Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Infectious Disease

Oral gepotidacin is non-inferior to standard therapy for uncomplicated urogenital gonorrhea

May 28, 2025
2 Minute Medicine Rewind May 20, 2019
Emergency

Point of care C-reactive protein testing may be useful in guiding antibiotic prescribing

December 6, 2024
Next Post
Diffusion tensor imaging valuable in the evaluation of peripheral neuropathy

Quality of life measures similar between teens with and without cerebral palsy

X-ray after foreign body removal by esophagoscopy is not cost effective

Beta-lactam monotherapy may be inferior to combination therapy in pneumonia

BRAF V600E mutations linked with increased mortality in thyroid cancer

Extraordinary response, and resistance, to everolimus in thyroid cancer pinned to mutations

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Chronic exposure to particulate matter is associated with increased cardiovascular risk
  • Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans
  • FDA-cleared AI devices rarely have patient outcome data
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.